Potent, Orally Active GPIIb/IIIa Antagonists Containing a Nipecotic Acid Subunit. Structure−Activity Studies Leading to the Discovery of RWJ-53308
- 13 November 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (25) , 5254-5265
- https://doi.org/10.1021/jm990418b
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Orally Active Isoxazoline GPIIb/IIIa AntagonistsCardiovascular Drug Reviews, 1998
- Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyJournal of the American College of Cardiology, 1996
- Non-Peptide Fibrinogen Receptor Antagonists. 7. Design and Synthesis of a Potent, Orally Active Fibrinogen Receptor AntagonistJournal of Medicinal Chemistry, 1995
- Cardiogenic ShockNew England Journal of Medicine, 1994
- Adamantane and Nipecotic Acid Derivatives as Novel β-Turn MimicsBioorganic & Medicinal Chemistry Letters, 1994
- Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future DirectionsJournal of Medicinal Chemistry, 1994
- Synthesis and NMD A Antagonistic Properties of the Enantiomers of 4‐(3‐phosphonopropyl)piperazine‐2‐carboxylic acid (CPP) and of the unsaturated analogue (E)‐4‐(3‐phosphonoprop‐2‐enyl)piperazine‐2‐carboxylic acid (CPP‐ene)Helvetica Chimica Acta, 1989
- Organoboron compounds in new synthetic reactionsPure and Applied Chemistry, 1985
- 4-(Diphenylmethyl)-1-(iminomethyl)piperidines as gastric antisecretory agentsJournal of Medicinal Chemistry, 1983
- Researches on Pyrimidines. CXLIX. The Synthesis of Aryl Substituted Dihydrouracils and their Conversion to Uracil Derivatives1Journal of the American Chemical Society, 1936